To test whether STAT3 drives the stem cell phenotype in breast cancer cells, we knocked down STAT3 gene by shRNAs and examined the CD44+ subpopulation by fluorescence activated cell sorting (FACS). The gene discussed is CD44; the disease is breast carcinoma.